OC
GSK icon

Opinicus Capital’s GSK GSK Stock Holding History

Opinicus Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,599
Closed -$433K – 97
2024
Q3 		$433K Sell
10,599
-304
-3% -$12.4K 0.35% 72
2024
Q2 		$420K Sell
10,903
-121
-1% -$5.09K 0.35% 71
2024
Q1 		$473K Sell
11,024
-262
-2% -$10.8K 0.42% 64
2023
Q4 		$418K Buy
+11,286
New +$405K 0.43% 64

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Opinicus Capital's GSK Position: Q4 2024 in Review

Opinicus Capital sold out of GSK (GSK) in Q4 2024, closing a stake of 10,599 shares — an estimated $433K sold.

Opinicus Capital first reported a position in GSK in Q4 2023 and held it in 4 quarters. The position peaked at $473K in Q1 2024. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • Opinicus Capital reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
  • Opinicus Capital sold 10,599 GSK shares in Q4 2024, an estimated $433K.
  • Opinicus Capital first reported a position in GSK in Q4 2023 and held it in 4 quarters.
  • Opinicus Capital's GSK position peaked at $473K in Q1 2024.
  • 848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Opinicus Capital's 13F filing for Q4 2024, filed 28 Jan 2025.